T D Cunningham1, B S Di Pace, J Ullal. 1. Graduate Program in Public Health, Eastern Virginia Medical School, Harry Lester Building, 651 Colley Avenue, Norfolk, VA, 23507, USA, CunninTD@EVMS.edu.
Abstract
UNLABELLED: We studied factors to determine the receipt of osteoporosis treatment in individuals with osteoporosis. Treatment was associated with age, gender, race, body mass index (BMI), family history, arthritis and thyroid problems, daily glucocorticoid use, number of prescriptions and healthcare visits, and insurance type. INTRODUCTION: Osteoporosis is underrecognized and undertreated. Few studies have examined factors associated with osteoporosis treatment in a large, national sample of men and women. METHODS: We aggregated National Health and Nutrition Examination Survey (NHANES) data from 2005 to 2010 and created a subsample which included individuals 50 years or older who were identified to have osteoporosis either by self-report data or by bone density measurements. The primary outcome was the receipt of osteoporosis treatment either from self-report or from prescription records. Covariates included sociodemographics, clinical characteristics, and access to healthcare variables. Logistic regression analyses were performed to determine factors that associate with osteoporosis treatment. RESULTS: From a sample of 31,0134 participants, 1,133 subjects (3.65 %) met the study criteria. Treatment was associated with age (odds ratio (OR) = 1.14), gender (OR = 13.25), race (OR = 2.23, White vs. Black; OR = 1.76, other vs. Black), BMI (OR = 1.67, normal vs. obese; OR = 2.68, overweight vs. obese), family history of osteoporosis (OR = 1.94), arthritis (OR = 1.43), daily glucocorticoid use (OR = 1.43), number of prescriptions (OR = 1.01), and number of healthcare visits in the past year (OR = 1.44, 4-9 vs. 0-3 visits). All odds ratios were statistically significant. CONCLUSION: A large number of individuals diagnosed with osteoporosis above the age of 50 remain untreated. It is important for healthcare providers to better assess older adults with osteoporosis, including individuals who frequently receive medical care.
UNLABELLED: We studied factors to determine the receipt of osteoporosis treatment in individuals with osteoporosis. Treatment was associated with age, gender, race, body mass index (BMI), family history, arthritis and thyroid problems, daily glucocorticoid use, number of prescriptions and healthcare visits, and insurance type. INTRODUCTION:Osteoporosis is underrecognized and undertreated. Few studies have examined factors associated with osteoporosis treatment in a large, national sample of men and women. METHODS: We aggregated National Health and Nutrition Examination Survey (NHANES) data from 2005 to 2010 and created a subsample which included individuals 50 years or older who were identified to have osteoporosis either by self-report data or by bone density measurements. The primary outcome was the receipt of osteoporosis treatment either from self-report or from prescription records. Covariates included sociodemographics, clinical characteristics, and access to healthcare variables. Logistic regression analyses were performed to determine factors that associate with osteoporosis treatment. RESULTS: From a sample of 31,0134 participants, 1,133 subjects (3.65 %) met the study criteria. Treatment was associated with age (odds ratio (OR) = 1.14), gender (OR = 13.25), race (OR = 2.23, White vs. Black; OR = 1.76, other vs. Black), BMI (OR = 1.67, normal vs. obese; OR = 2.68, overweight vs. obese), family history of osteoporosis (OR = 1.94), arthritis (OR = 1.43), daily glucocorticoid use (OR = 1.43), number of prescriptions (OR = 1.01), and number of healthcare visits in the past year (OR = 1.44, 4-9 vs. 0-3 visits). All odds ratios were statistically significant. CONCLUSION: A large number of individuals diagnosed with osteoporosis above the age of 50 remain untreated. It is important for healthcare providers to better assess older adults with osteoporosis, including individuals who frequently receive medical care.
Authors: Daniel H Solomon; Charles Morris; Hailu Cheng; Danielle Cabral; Jeffrey N Katz; Joel S Finkelstein; Jerry Avorn Journal: Mayo Clin Proc Date: 2005-02 Impact factor: 7.616
Authors: Susan L Greenspan; Allison Wyman; Frederick H Hooven; Silvano Adami; Stephen Gehlbach; Frederick A Anderson; Steven Boone; Andrea Z Lacroix; Robert Lindsay; J Coen Netelenbos; Johannes Pfeilschifter; Stuart Silverman; Ethel S Siris; Nelson B Watts Journal: J Am Geriatr Soc Date: 2012-02-08 Impact factor: 5.562
Authors: Ramona S DeJesus; Rajeev Chaudhry; Kurt B Angstman; Stephen S Cha; Sidna M Tulledge-Scheitel; Rebecca L Kesman; Matthew E Bernard; Robert J Stroebel Journal: Popul Health Manag Date: 2011-04-20 Impact factor: 2.459
Authors: M A Ward; Y Xu; H N Viswanathan; B S Stolshek; B Clay; J L Adams; J D Kallich; S Fine; K G Saag Journal: Osteoporos Int Date: 2012-10-26 Impact factor: 4.507
Authors: Jeffrey R Curtis; Leslie A McClure; Elizabeth Delzell; Virginia J Howard; Eric Orwoll; Kenneth G Saag; Monika Safford; George Howard Journal: J Gen Intern Med Date: 2009-06-24 Impact factor: 5.128
Authors: Shih-Feng Weng; Hui-Ru Hsu; Yao-Lin Weng; Kai-Jen Tien; Hao-Yun Kao Journal: Int J Environ Res Public Health Date: 2020-02-10 Impact factor: 3.390
Authors: R Y van der Velde; C E Wyers; E Teesselink; P P M M Geusens; J P W van den Bergh; F de Vries; C Cooper; N C Harvey; T P van Staa Journal: Bone Date: 2016-10-11 Impact factor: 4.398
Authors: J Talevski; K M Sanders; J J Watts; G C Nicholson; E Seeman; S Iuliano; R Prince; L March; T Winzenberg; G Duque; P R Ebeling; F Borgström; J A Kanis; A L Stuart; A Beauchamp; S L Brennan-Olsen Journal: Osteoporos Int Date: 2021-07-08 Impact factor: 4.507
Authors: Carolyn J Crandall; Rebecca P Hunt; Andrea Z LaCroix; John A Robbins; Jean Wactawski-Wende; Karen C Johnson; Maryam Sattari; Katie L Stone; Julie C Weitlauf; Tanya R Gure; Jane A Cauley Journal: EClinicalMedicine Date: 2021-05-05